Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lo

Showing results (1041-1050 of 1,300) with videos related to

Pageof 130
Sort By:
Annals of Palliative Medicine|October 11, 2023
Emergent radiotherapy for spinal cord compression/impingement-a narrative reviewPeter Zaki, Andrew Barbour, Mark M Zaki, et al.
Clinical Chemistry and Laboratory Medicine|December 8, 2023
Ensuring quality in 17OHP mass spectrometry measurement: an international study assessing isomeric steroid interferenceChung Shun Ho, Kirsten Hoad, Brian R Cooke, et al.
Cell|March 22, 2016
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic MelanomaWilly Hugo, Jesse M Zaretsky, Lu Sun, et al.
Cancer Discovery|September 3, 2017
Recurrent Tumor Cell-Intrinsic and -Extrinsic Alterations during MAPKi-Induced Melanoma Regression and Early AdaptationChunying Song, Marco Piva, Lu Sun, et al.
The Journal of Clinical Investigation|June 9, 2016
Soluble fms-like tyrosine kinase 1 promotes angiotensin II sensitivity in preeclampsiaSuzanne D Burke, Zsuzsanna K Zsengellér, Eliyahu V Khankin, et al.
Arthritis Care & Research|May 29, 2018
Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for Juvenile Idiopathic Arthritis-Associated and Idiopathic Chronic Anterior UveitisSheila T Angeles-Han, Mindy S Lo, Lauren A Henderson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2025
TRADE: a phase II trial to assess the tolerability of abemaciclib dose escalation in early-stage HR-positive/HER2-negative breast cancerE L Mayer, D Trapani, S-E Kim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2012
Clostridium difficile ribotype does not predict severe infectionSeth T Walk, Dejan Micic, Ruchika Jain, et al.
Cancer|January 23, 2024
A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancersAlain P Algazi, James Moon, Christopher D Lao, et al.
Prostate Cancer|June 27, 2022
Expansion of Lymphocytes from Prostatic Adenocarcinoma and Adjacent Nonmalignant TissueLinh T Nguyen, Charlotte S Lo, Michael Fyrsta, et al.
Pageof 130

Showing results (1041-1050 of 1,300) with videos related to

Sort By:
Pageof 130
Annals of Palliative Medicine|October 11, 2023
Emergent radiotherapy for spinal cord compression/impingement-a narrative reviewPeter Zaki, Andrew Barbour, Mark M Zaki, et al.
Clinical Chemistry and Laboratory Medicine|December 8, 2023
Ensuring quality in 17OHP mass spectrometry measurement: an international study assessing isomeric steroid interferenceChung Shun Ho, Kirsten Hoad, Brian R Cooke, et al.
Cell|March 22, 2016
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic MelanomaWilly Hugo, Jesse M Zaretsky, Lu Sun, et al.
Cancer Discovery|September 3, 2017
Recurrent Tumor Cell-Intrinsic and -Extrinsic Alterations during MAPKi-Induced Melanoma Regression and Early AdaptationChunying Song, Marco Piva, Lu Sun, et al.
The Journal of Clinical Investigation|June 9, 2016
Soluble fms-like tyrosine kinase 1 promotes angiotensin II sensitivity in preeclampsiaSuzanne D Burke, Zsuzsanna K Zsengellér, Eliyahu V Khankin, et al.
Arthritis Care & Research|May 29, 2018
Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for Juvenile Idiopathic Arthritis-Associated and Idiopathic Chronic Anterior UveitisSheila T Angeles-Han, Mindy S Lo, Lauren A Henderson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2025
TRADE: a phase II trial to assess the tolerability of abemaciclib dose escalation in early-stage HR-positive/HER2-negative breast cancerE L Mayer, D Trapani, S-E Kim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2012
Clostridium difficile ribotype does not predict severe infectionSeth T Walk, Dejan Micic, Ruchika Jain, et al.
Cancer|January 23, 2024
A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancersAlain P Algazi, James Moon, Christopher D Lao, et al.
Prostate Cancer|June 27, 2022
Expansion of Lymphocytes from Prostatic Adenocarcinoma and Adjacent Nonmalignant TissueLinh T Nguyen, Charlotte S Lo, Michael Fyrsta, et al.
Pageof 130